File Under:

Two Decades Of Alzheimer’s Research Was Based On Deliberate Fraud

At a glance

  • The original paper that established the amyloid plaque model as the foundation of Alzheimer’s research over the last 16 years might not just be wrong, but a deliberate fraud.
  • The suspicion that something was more than a little wrong with the model that is getting almost all Alzheimer’s research funding ($1.6 billion in the last year alone) began with a fight over the drug Simufilam.
  • The drug was being pushed into trials by its manufacturer, Cassava Sciences, but a group of scientists who reviewed the drug maker’s claims about Simufilam believed that it was exaggerating the potential.



More Stories

September 24, 2022
After House Minority Leader Kevin McCarthy unveiled his vision for a GOP-led House, Illinois Republican Rep. Adam Kinzinger called the plan "an opportunity squandered" because instead presenting good policy McCarthy chose instead to “bow” to the “MAGA” wing of the party for political gain.